Latest healthtech and biotech deals
The largest from last week:
🇬🇧 Cera, digital-first home healthcare, raised $320M in equity and debt investment. The healthtech company operates in the UK and Germany, giving at-home care that is more affordable than a patient receiving care in a hospital, due to its technology-powered model.
🇬🇧 F2G, a clinical-stage biopharma company focused on therapies to treat life-threatening rare fungal infections with a high unmet medical need, has announced $70M.
Other notable deals from around the globe:
🇨🇳 InSilico Medicine, a clinical-stage end-to-end AI-driven drug discovery company, announced today that it has completed a $35M, bringing the total raised in Series D to $95M.
🇺🇸 Sibel Health, developer of a neonatal epidermal system designed for wireless vital signs monitoring, raised $33M in Series B. The company said that the funding will support its FDA-cleared Anne One platform for global deployments across the continuum of care from the home to the hospital.
🇺🇸 Biofourmis, remote monitoring and home care company, raised $20M to complete $320M in Series D. The company plans to expand its virtual offerings including building digital therapeutics, funding more clinical trials and inking strategic partnerships with digital health companies.
Read up on all the latest health deals in Dealroom.co